Diedrich Gundo
diaDexus Inc., South San Francisco, CA 94080, USA.
FEBS J. 2006 Sep;273(17):3871-85. doi: 10.1111/j.1742-4658.2006.05379.x.
Hepatitis C virus (HCV) exists in different forms in the circulation of infected people: lipoprotein bound and lipoprotein free, enveloped and nonenveloped. Viral particles with the highest infectivity are associated with lipoproteins, whereas lipoprotein-free virions are poorly infectious. The detection of HCV's envelope proteins E1 and E2 in lipoprotein-associated virions has been challenging. Because lipoproteins are readily endocytosed, some forms of HCV might utilize their association with lipoproteins rather than E1 and E2 for cell attachment and internalization. However, vaccination of chimpanzees with recombinant envelope proteins protected the animals from hepatitis C infection, suggesting an important role for E1 and E2 in cell entry. It seems possible that different forms of HCV use different receptors to attach to and enter cells. The putative receptors and the assays used for their validation are discussed in this review.
丙型肝炎病毒(HCV)在受感染人群的循环系统中以不同形式存在:与脂蛋白结合及游离于脂蛋白之外,有包膜及无包膜。传染性最强的病毒颗粒与脂蛋白相关,而无脂蛋白的病毒体传染性较弱。在与脂蛋白相关的病毒体中检测HCV包膜蛋白E1和E2颇具挑战性。由于脂蛋白易于被内吞,某些形式的HCV可能利用其与脂蛋白的结合而非E1和E2来实现细胞附着和内化。然而,用重组包膜蛋白对黑猩猩进行疫苗接种可保护动物免受丙型肝炎感染,这表明E1和E2在细胞进入过程中起重要作用。不同形式的HCV似乎可能利用不同受体附着并进入细胞。本综述将讨论假定的受体及其验证所用的检测方法。